Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles-Reference-Cited by-同舟云学术

Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles

Published:2022-01-11 Issue: Volume: Page:2107070
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Advanced Materials

Author:

Wang Zhicheng¹,Hood Elizabeth D.²,Nong Jia²,Ding Jing³,Marcos‐Contreras Oscar A.²,Glassman Patrick M.²,Rubey Kathryn M.⁴,Zaleski Michael¹,Espy Carolann L.²,Gullipali Damodara²,Miwa Takashi²,Muzykantov Vladimir R.²,Song Wen‐Chao²,Myerson Jacob W.²,Brenner Jacob S.¹^ORCID

Affiliation:

1. Department of Medicine and Department of Pharmacology University of Pennsylvania Philadelphia PA 19104 USA

2. Department of Pharmacology University of Pennsylvania Philadelphia PA 19104 USA

3. Department of Pediatrics Peking University People's Hospital Beijing 100044 China

4. Department of Pediatrics Children's Hospital of Philadelphia Philadelphia PA 19104 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202107070

Reference37 articles.

1. The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses

2. Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities

3. Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine

4. Evolution of the complement system

5. Stealth Coating of Nanoparticles in Drug-Delivery Systems

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances with erythrocytes as therapeutics carriers;International Journal of Pharmaceutics;2024-11

2. Nanocarriers' repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacy;Journal of Controlled Release;2024-10

3. Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial System;ACS Nano;2024-08-06

4. Developing targeted antioxidant nanomedicines for ischemic penumbra: Novel strategies in treating brain ischemia-reperfusion injury;Redox Biology;2024-07

5. Immunogenicity of Extracellular Vesicles;Advanced Materials;2024-06-27